Curaleaf exploring secondary listing in Europe, FT reports

Curaleaf is considering a secondary listing in Europe following legalization in Germany, The Financial Times’ Arjun Neil Alim and Eri Sugiura report. “We’re very much interested in a European listing”, said Juan Martinez, the head of Curaleaf International, who added that current restrictions meant “the only listing in Europe that is possible is a very limited listing in the second board of Frankfurt,” but that “We are actively exploring avenues to bolster shareholder value, which includes discussions with various exchanges, including those in Germany and London.”